Secukinumab in a patient with sarcoidosis

Yükleniyor...
Küçük Resim

Tarih

2020

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Taylor and Francis Ltd

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

Sarcoidosis is a systemic granulomatous disease, characterized by non-caseating granuloma formation. It usually involves the lungs, but may also affect the eyes, heart, skin, and musculoskeletal system. The pathogenesis is not well known, but it is generally accepted as Th1 disease. The role of Th17-induced cytokines in the development of sarcoid granuloma has been reported.

Açıklama

Anahtar Kelimeler

Kaynak

Scandinavian Journal of Rheumatology

WoS Q Değeri

Q3

Scopus Q Değeri

Q2

Cilt

Sayı

Künye

Kobak, S., Gungen, A. C., Gungen, B. D., Tutpinar, Y., & Guler, M. (2020). Secukinumab in a patient with sarcoidosis. Scandinavian Journal of Rheumatology, 1-2.